Evidence map›Paper›PMID 33000918›Full record

ArticleJournal of the International AIDS Society2020

HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project.

Patrick S Sullivan, Nancy Phaswana-Mafuya, Stefan D Baral, Rachel Valencia, Ryan Zahn, Karen Dominguez, Clarence S Yah, Jeb Jones, Lesego B Kgatitswe, A D McNaghten and 3 more

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. International journal of qualitative studies on health and well-being · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Patrick S SullivanRollins School of Public Health, Emory University, Atlanta, GA, USA.ORCID 0000-0002-7728-0587
Nancy Phaswana-MafuyaDVC Research and Innovation Office, North West University, Potchefstroom, South Africa.
Stefan D BaralBloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0002-5482-2419
Rachel ValenciaRollins School of Public Health, Emory University, Atlanta, GA, USA.
Ryan ZahnRollins School of Public Health, Emory University, Atlanta, GA, USA.
Karen DominguezRollins School of Public Health, Emory University, Atlanta, GA, USA.
Clarence S YahWits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0003-1601-1516
Jeb JonesRollins School of Public Health, Emory University, Atlanta, GA, USA.ORCID 0000-0001-9165-1658
Lesego B KgatitsweHuman Sciences Research Council of South Africa, Port Elizabeth, South Africa.
A D McNaghtenRollins School of Public Health, Emory University, Atlanta, GA, USA.
Aaron J SieglerRollins School of Public Health, Emory University, Atlanta, GA, USA.ORCID 0000-0001-5553-7540
Travis H SanchezRollins School of Public Health, Emory University, Atlanta, GA, USA.
Linda-Gail BekkerDesmond Tutu HIV Center, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-0755-4386

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Comprehensive HIV Prevention Package for MSM in Southern AfricaR01AI094575 · NIAID · EMORY UNIVERSITY · PI SULLIVAN, PATRICK SEAN · 2011 to 2014
$3.3M
NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI094575NIH HHS P30AI050409NIH HHS R01AI094575
6 · The paper itself

Abstract

introductionMen who have sex with men (MSM) and transgender women (TGW) are at increased risk for acquiring HIV, but there are limited HIV incidence data for these key populations in Africa. Understanding HIV prevalence and incidence provides important context for designing HIV prevention strategies, including pre-exposure prophylaxis (PrEP) programmes. We describe HIV prevalence, awareness of HIV infection, HIV incidence and associated factors for a cohort of MSM and TGW in Cape Town and Port Elizabeth, South Africa.

methodsFrom 2015 to 2016, MSM and TGW in Cape Town and Port Elizabeth were enrolled and prospectively followed for 12 months, receiving a comprehensive package of HIV prevention services. HIV testing was conducted at baseline and at follow-up visits (targeted for three, six and twelve months). All HIV-negative PrEP-eligible participants were offered PrEP enrolment during the first four months of study participation. We determined HIV prevalence among participants at baseline, and incidence by repeat screening of initially HIV-negative participants with HIV tests at three, six and twelve months.

resultsAmong 292 participants enrolled, HIV prevalence was high (43%; 95% CI: 38 to 49) and awareness of HIV status was low (50%). The 167 HIV-negative participants who were followed prospectively for 144.7 person-years; nine incident HIV infections were documented. Overall annual incidence was 6.2% (CI: 2.8 to 11.8) and did not differ by city. Annual HIV incidence was significantly higher for younger (18 to 19 years) MSM and TGW (MSM: 21.8% (CI: 1.2 to 100); TGW: 31.0 (CI: 3.7, 111.2)). About half of participants started PrEP during the study; the annual incidence of HIV among 82 (49%) PrEP starters was 3.6% (CI: 0.4, 13.1) and among those who did not start PrEP was 7.8% (CI: 3.1, 16.1).

conclusionsHIV incidence was high among MSM and TGW in the context of receiving a comprehensive package of prevention interventions and offering of PrEP. PrEP uptake was high; the observed incidence of HIV in those who started PrEP was about half the incidence of HIV in those who did not. Future implementation-oriented studies should focus on decisions to start and continue PrEP for those at highest risk, including young MSM.

Indexed as

Homosexuality, MaleSexual and Gender MinoritiesTransgender PersonsAdolescentAdultAnti-HIV AgentsBlack PeopleCitiesCohort StudiesFemaleHIV InfectionsHumansIncidenceMaleMass ScreeningPre-Exposure ProphylaxisAnti-HIV Agentscohort studiesHIVHIV preventionmen who have sex with menpre-exposure prophylaxissexually transmitted infections

Identifiers

PMID33000918
PMCPMC7527763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.